The shRNA set 1-mediated stable knockdown (KD) of FGFR2 resulted in suppressed cell growth in vitro (Figure S1H), reduced tumor growth in nude mice (n = 10) (Figure 1A), and reduced tumor sphere formation in vitro (Figure 1B). The gene discussed is FGFR2; the disease is neoplasm.